Interactions involving children span a wide range of important domains from learning to clinical diagnostic and therapeutic contexts. Automated analyses of such interactions are motivated by the need to seek accurate insights and offer scale and robustness across diverse and wide-ranging conditions. Identifying the speech segments belonging to the child is a critical step in such modeling. Conventional child-adult speaker classification typically relies on audio modeling approaches, overlooking visual signals that convey speech articulation information, such as lip motion. Building on the foundation of an audio-only child-adult speaker classification pipeline, we propose incorporating visual cues through active speaker detection and visual processing models. Our framework involves video pre-processing, utterance-level child-adult speaker detection, and late fusion of modality-specific predictions. We demonstrate from extensive experiments that a visually aided classification pipeline enhances the accuracy and robustness of the classification. We show relative improvements of 2.38% and 3.97% in F1 macro score when one face and two faces are visible, respectively.
Speech processing techniques are useful for analyzing speech and language development in children with Autism Spectrum Disorder (ASD), who are often varied and delayed in acquiring these skills. Early identification and intervention are crucial, but traditional assessment methodologies such as caregiver reports are not adequate for the requisite behavioral phenotyping. Natural Language Sample (NLS) analysis has gained attention as a promising complement. Researchers have developed benchmarks for spoken language capabilities in children with ASD, obtainable through the analysis of NLS. This paper proposes applications of speech processing technologies in support of automated assessment of children's spoken language development by classification between child and adult speech and between speech and nonverbal vocalization in NLS, with respective F1 macro scores of 82.6% and 67.8%, underscoring the potential for accurate and scalable tools for ASD research and clinical use.